Sontag Advisory »

Alaunos Therapeutics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Alaunos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $3 1 3.00

More positions owned by Sontag Advisory

iShares Core S&P 500 ETF Etf (IVV)
Vanguard MSCI EAFE ETF Etf (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab International Equity ETF Etf (SCHF)
Vanguard FTSE Emerging Markets ETF Etf (VWO)
Vanguard Index Fds Growth Etf (VUG)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Extended Market ETF Etf (VXF)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Sontag Advisory

Top funds holding Alaunos Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
Tower Research Capital
UBS Group
Advisor Group Holdings
Atlantic Trust
Royal Bank of Canada
Wells Fargo & Company
Ronald Blue Trust
Steward Partners Investment Advisory
Federation des caisses Desjardins du Quebec
Barclays
Newbridge Financial Services Group
Key FInancial

View all funds holding Alaunos Therapeutics